Literature DB >> 28494579

Multiparametric prostate MRI: technical conduct, standardized report and clinical use.

Matteo Manfredi1, Fabrizio Mele2, Diletta Garrou2, Jochen Walz3, Jurgen J Fütterer4, Filippo Russo5, Lorenzo Vassallo5, Arnauld Villers6, Mark Emberton7, Massimo Valerio8.   

Abstract

Multiparametric prostate MRI (mp-MRI) is an emerging imaging modality for diagnosis, characterization, staging, and treatment planning of prostate cancer (PCa). The technique, results reporting, and its role in clinical practice have been the subject of significant development over the last decade. Although mp-MRI is not yet routinely used in the diagnostic pathway, almost all urological guidelines have emphasized the potential role of mp-MRI in several aspects of PCa management. Moreover, new MRI sequences and scanning techniques are currently under evaluation to improve the diagnostic accuracy of mp-MRI. This review presents an overview of mp-MRI, summarizing the technical applications, the standardized reporting systems used, and their current roles in various stages of PCa management. Finally, this critical review also reports the main limitations and future perspectives of the technique.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28494579     DOI: 10.23736/S0393-2249.17.02846-6

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  9 in total

1.  Magnetic Resonance Features of Acquired Immune Deficiency Syndrome Involving Central Nervous System Diseases by Intelligent Fuzzy C-Means Clustering (FCM) Algorithm.

Authors:  Gang Huang; Jiaqi Chen; Yuli Ge; Xiaomei Zhu; Meixiao Ding; Xugao Chen; Chunsheng Qu
Journal:  Comput Math Methods Med       Date:  2022-07-05       Impact factor: 2.809

2.  Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer.

Authors:  Lu Ma; Qi Zhou; Huming Yin; Xiaojie Ang; Yu Li; Gansheng Xie; Gang Li
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

3.  Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.

Authors:  Arjun Sivaraman; Giancarlo Marra; Armando Stabile; Annick Mombet; Petr Macek; Camille Lanz; Nathalie Cathala; Marco Moschini; Arie Carneiro; Rafael Sanchez-Salas; Xavier Cathelineau
Journal:  Int Braz J Urol       Date:  2020 Nov-Dec       Impact factor: 1.541

4.  The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering.

Authors:  Seyed Masoud Rezaeijo; Bijan Hashemi; Bahram Mofid; Mohsen Bakhshandeh; Arash Mahdavi; Mohammad Saber Hashemi
Journal:  Radiat Oncol       Date:  2021-09-20       Impact factor: 3.481

5.  Evaluation and Monitoring of Endometrial Cancer Based on Magnetic Resonance Imaging Features of Deep Learning.

Authors:  Jingxiong Tao; Yi Wang; Yi Liang; Aohua Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-03-18       Impact factor: 3.161

6.  Diagnostic Value of MRI Combined with CXCR4 Expression Level in Lymph Node Metastasis Head and Neck Squamous Cell Carcinoma.

Authors:  Jin Zhao; Xingde Li; Ming Wang; Fenghai Liu; Jingrun Wang
Journal:  Comput Math Methods Med       Date:  2022-03-08       Impact factor: 2.238

7.  Artificial Intelligence Algorithm-Based MRI for Differentiation Diagnosis of Prostate Cancer.

Authors:  Rui Luo; Qingxiang Zeng; Huashan Chen
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

8.  Magnetic Resonance Imaging Image Feature Analysis Algorithm under Convolutional Neural Network in the Diagnosis and Risk Stratification of Prostate Cancer.

Authors:  Weijun Gao; Peibo Zhang; Hui Wang; Pengfei Tuo; Zhiqing Li
Journal:  J Healthc Eng       Date:  2021-11-27       Impact factor: 2.682

9.  Clinical Significance of Color Ultrasound, MRI, miR-21, and CA199 in the Diagnosis of Pancreatic Cancer.

Authors:  Jing Yu; Xue Yang; Hongmei Wu; Jiansheng Li
Journal:  J Oncol       Date:  2021-07-28       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.